Ergosterol isolated from the basidiomycete Pleurotus salmoneostramineus affects Trypanosoma cruzi plasma membrane and mitochondria

Abstract Background Major drawbacks of the available treatment against Chagas disease (American trypanosomiasis) include its toxicity and therapeutic inefficiency in the chronic phase of the infection, which makes it a concern among neglected diseases. Therefore, the discovery of alternative drugs f...

Full description

Bibliographic Details
Published in:Journal of Venomous Animals and Toxins including Tropical Diseases
Main Authors: Tatiana Rodrigues Alexandre, Marta Lopes Lima, Mariana Kolos Galuppo, Juliana Tonini Mesquita, Matilia Ana do Nascimento, Augusto Leonardo dos Santos, Patricia Sartorelli, Daniel Carvalho Pimenta, Andre Gustavo Tempone
Format: Article in Journal/Newspaper
Language:English
Published: SciELO 2017
Subjects:
Online Access:https://doi.org/10.1186/s40409-017-0120-0
https://doaj.org/article/217baf611d2145858a80082097335587
id ftdoajarticles:oai:doaj.org/article:217baf611d2145858a80082097335587
record_format openpolar
spelling ftdoajarticles:oai:doaj.org/article:217baf611d2145858a80082097335587 2023-05-15T15:14:15+02:00 Ergosterol isolated from the basidiomycete Pleurotus salmoneostramineus affects Trypanosoma cruzi plasma membrane and mitochondria Tatiana Rodrigues Alexandre Marta Lopes Lima Mariana Kolos Galuppo Juliana Tonini Mesquita Matilia Ana do Nascimento Augusto Leonardo dos Santos Patricia Sartorelli Daniel Carvalho Pimenta Andre Gustavo Tempone 2017-05-01T00:00:00Z https://doi.org/10.1186/s40409-017-0120-0 https://doaj.org/article/217baf611d2145858a80082097335587 EN eng SciELO http://link.springer.com/article/10.1186/s40409-017-0120-0 https://doaj.org/toc/1678-9199 doi:10.1186/s40409-017-0120-0 1678-9199 https://doaj.org/article/217baf611d2145858a80082097335587 Journal of Venomous Animals and Toxins including Tropical Diseases, Vol 23, Iss 1, Pp 1-10 (2017) Pleurotus salmoneostramineus Ergosterol Trypanosoma cruzi Mechanism of action Arctic medicine. Tropical medicine RC955-962 Toxicology. Poisons RA1190-1270 Zoology QL1-991 article 2017 ftdoajarticles https://doi.org/10.1186/s40409-017-0120-0 2022-12-31T00:59:51Z Abstract Background Major drawbacks of the available treatment against Chagas disease (American trypanosomiasis) include its toxicity and therapeutic inefficiency in the chronic phase of the infection, which makes it a concern among neglected diseases. Therefore, the discovery of alternative drugs for treating chronic Chagas disease requires immediate action. In this work, we evaluated the mushroom Pleurotus salmoneostramineus in the search for potential antiparasitic compounds. Methods Fruit bodies of the basidiomycete Pleurotus salmoneostramineus were triturated and submitted to organic solvent extraction. After liquid-liquid partition of the crude extract, three fractions were obtained and the bioguided fractionation study was conducted to isolate the active metabolites. The elucidation of the chemical structure was performed using GC-MS and NMR techniques. The biological assays for antiparasitic activity were carried out using trypomastigotes of Trypanosoma cruzi and murine macrophages for mammalian cytotoxicity. The mechanism of action of the isolated compound used different fluorescent probes to evaluate the plasma membrane permeability, the potential of the mitochondrial membrane and the intracellular levels of reactive oxygen species (ROS). Results The most abundant fraction showing the antiparasitic activity was isolated and chemically elucidated, confirming the presence of ergosterol. It showed anti-Trypanosoma cruzi activity against trypomastigotes, with an IC50 value of 51.3 μg/mL. The compound demonstrated no cytotoxicity against mammalian cells to the maximal tested concentration of 200 μg/mL. The mechanism of action of ergosterol in Trypanosoma cruzi trypomastigotes resulted in permeabilization of the plasma membrane, as well as depolarization of mitochondrial membrane potential, leading to parasite death. Nevertheless, no increase in ROS levels could be observed, suggesting damages to plasma membrane rather than an induction of oxidative stress in the parasite. Conclusions The selection of ... Article in Journal/Newspaper Arctic Directory of Open Access Journals: DOAJ Articles Arctic Journal of Venomous Animals and Toxins including Tropical Diseases 23 1
institution Open Polar
collection Directory of Open Access Journals: DOAJ Articles
op_collection_id ftdoajarticles
language English
topic Pleurotus salmoneostramineus
Ergosterol
Trypanosoma cruzi
Mechanism of action
Arctic medicine. Tropical medicine
RC955-962
Toxicology. Poisons
RA1190-1270
Zoology
QL1-991
spellingShingle Pleurotus salmoneostramineus
Ergosterol
Trypanosoma cruzi
Mechanism of action
Arctic medicine. Tropical medicine
RC955-962
Toxicology. Poisons
RA1190-1270
Zoology
QL1-991
Tatiana Rodrigues Alexandre
Marta Lopes Lima
Mariana Kolos Galuppo
Juliana Tonini Mesquita
Matilia Ana do Nascimento
Augusto Leonardo dos Santos
Patricia Sartorelli
Daniel Carvalho Pimenta
Andre Gustavo Tempone
Ergosterol isolated from the basidiomycete Pleurotus salmoneostramineus affects Trypanosoma cruzi plasma membrane and mitochondria
topic_facet Pleurotus salmoneostramineus
Ergosterol
Trypanosoma cruzi
Mechanism of action
Arctic medicine. Tropical medicine
RC955-962
Toxicology. Poisons
RA1190-1270
Zoology
QL1-991
description Abstract Background Major drawbacks of the available treatment against Chagas disease (American trypanosomiasis) include its toxicity and therapeutic inefficiency in the chronic phase of the infection, which makes it a concern among neglected diseases. Therefore, the discovery of alternative drugs for treating chronic Chagas disease requires immediate action. In this work, we evaluated the mushroom Pleurotus salmoneostramineus in the search for potential antiparasitic compounds. Methods Fruit bodies of the basidiomycete Pleurotus salmoneostramineus were triturated and submitted to organic solvent extraction. After liquid-liquid partition of the crude extract, three fractions were obtained and the bioguided fractionation study was conducted to isolate the active metabolites. The elucidation of the chemical structure was performed using GC-MS and NMR techniques. The biological assays for antiparasitic activity were carried out using trypomastigotes of Trypanosoma cruzi and murine macrophages for mammalian cytotoxicity. The mechanism of action of the isolated compound used different fluorescent probes to evaluate the plasma membrane permeability, the potential of the mitochondrial membrane and the intracellular levels of reactive oxygen species (ROS). Results The most abundant fraction showing the antiparasitic activity was isolated and chemically elucidated, confirming the presence of ergosterol. It showed anti-Trypanosoma cruzi activity against trypomastigotes, with an IC50 value of 51.3 μg/mL. The compound demonstrated no cytotoxicity against mammalian cells to the maximal tested concentration of 200 μg/mL. The mechanism of action of ergosterol in Trypanosoma cruzi trypomastigotes resulted in permeabilization of the plasma membrane, as well as depolarization of mitochondrial membrane potential, leading to parasite death. Nevertheless, no increase in ROS levels could be observed, suggesting damages to plasma membrane rather than an induction of oxidative stress in the parasite. Conclusions The selection of ...
format Article in Journal/Newspaper
author Tatiana Rodrigues Alexandre
Marta Lopes Lima
Mariana Kolos Galuppo
Juliana Tonini Mesquita
Matilia Ana do Nascimento
Augusto Leonardo dos Santos
Patricia Sartorelli
Daniel Carvalho Pimenta
Andre Gustavo Tempone
author_facet Tatiana Rodrigues Alexandre
Marta Lopes Lima
Mariana Kolos Galuppo
Juliana Tonini Mesquita
Matilia Ana do Nascimento
Augusto Leonardo dos Santos
Patricia Sartorelli
Daniel Carvalho Pimenta
Andre Gustavo Tempone
author_sort Tatiana Rodrigues Alexandre
title Ergosterol isolated from the basidiomycete Pleurotus salmoneostramineus affects Trypanosoma cruzi plasma membrane and mitochondria
title_short Ergosterol isolated from the basidiomycete Pleurotus salmoneostramineus affects Trypanosoma cruzi plasma membrane and mitochondria
title_full Ergosterol isolated from the basidiomycete Pleurotus salmoneostramineus affects Trypanosoma cruzi plasma membrane and mitochondria
title_fullStr Ergosterol isolated from the basidiomycete Pleurotus salmoneostramineus affects Trypanosoma cruzi plasma membrane and mitochondria
title_full_unstemmed Ergosterol isolated from the basidiomycete Pleurotus salmoneostramineus affects Trypanosoma cruzi plasma membrane and mitochondria
title_sort ergosterol isolated from the basidiomycete pleurotus salmoneostramineus affects trypanosoma cruzi plasma membrane and mitochondria
publisher SciELO
publishDate 2017
url https://doi.org/10.1186/s40409-017-0120-0
https://doaj.org/article/217baf611d2145858a80082097335587
geographic Arctic
geographic_facet Arctic
genre Arctic
genre_facet Arctic
op_source Journal of Venomous Animals and Toxins including Tropical Diseases, Vol 23, Iss 1, Pp 1-10 (2017)
op_relation http://link.springer.com/article/10.1186/s40409-017-0120-0
https://doaj.org/toc/1678-9199
doi:10.1186/s40409-017-0120-0
1678-9199
https://doaj.org/article/217baf611d2145858a80082097335587
op_doi https://doi.org/10.1186/s40409-017-0120-0
container_title Journal of Venomous Animals and Toxins including Tropical Diseases
container_volume 23
container_issue 1
_version_ 1766344725594374144